Mr. Chair, the models that are presented represent an ongoing refinement of our understanding of SARS-CoV-2 as the science continues to evolve and as we learn more about a number of parameters, including transmission, reproduction number and vaccine efficacy. These models are updated and are presented.
The assumptions are available and are made available to researchers and to those who are interested, recognizing—